Drug Shortage Report for DONEPEZIL
| Report ID | 216058 |
| Drug Identification Number | 02475278 |
| Brand name | DONEPEZIL |
| Common or Proper name | Donepezil 5mg |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DONEPEZIL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-01-12 |
| Actual start date | 2024-01-12 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-01-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-01-15 | French | Compare |
| v1 | 2024-01-15 | English | Compare |
Showing 1 to 2 of 2